Literature DB >> 18997557

Necrotizing soft-tissue infections: differences in patients treated at burn centers and non-burn centers.

Frederick W Endorf1, Matthew B Klein, Christopher D Mack, Gregory J Jurkovich, Frederick P Rivara.   

Abstract

Necrotizing soft-tissue infections (NSTI) are often life-threatening illnesses that may be best treated at specialty care facilities such as burn centers. However, little is known about current treatment patterns nationwide. The purpose of this study was to describe the referral patterns for treatment of NSTI using a multistate discharge database and to investigate the differences in patients with NSTIs treated at burn centers and nonburn centers. The National Inpatient Sample is an all-payer inpatient database from 37 states containing data from 14 million hospital stays each year. We identified all patients with NSTI using International Classification of Disease version 9 codes for necrotizing fasciitis (728.86), gas gangrene (040.0), and Fournier's gangrene (608.83) for the years 2001 and 2004. Patients were dichotomized by location of definitive treatment--either burn centers or nonburn centers. Burn center status was ascertained from the current American Burn Association burn center directory. Patient characteristics, payer status, hospital course, mortality rates, and disposition were compared between patients treated at burn centers and nonburn centers. In 2001 and 2004, a total of 10,940 patients were identified as having a NSTI. The majority (87.1%) of these patients received definitive care at nonburn centers. Patients treated at burn centers were more likely to be transferred from another hospital (OR 2.0, CI 1.8-2.2) and were more likely to have Medicaid (22.6% vs 16.3%, OR 1.39) or be uninsured (18.8% vs 13.7%, OR 1.38). Patients treated at burn centers had more surgical procedures (4.6 vs 4.3, P < .01), and higher hospital charges ($101,800 vs $68,500, P < .01). Total length of stay was also longer at burn centers (22.1 vs 16.0 days, P < .01). Based on a national discharge database, the majority of patients with NSTI are treated at nonburn centers. However, patients treated at burn centers were more likely to be transferred from nonburn centers, had longer lengths of stay, and underwent more operations, all of which are likely attributable to a greater severity of infection.

Entities:  

Mesh:

Year:  2008        PMID: 18997557      PMCID: PMC3042354          DOI: 10.1097/BCR.0b013e31818ba112

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  18 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era.

Authors:  K A Robinson; W Baughman; G Rothrock; N L Barrett; M Pass; C Lexau; B Damaske; K Stefonek; B Barnes; J Patterson; E R Zell; A Schuchat; C G Whitney
Journal:  JAMA       Date:  2001-04-04       Impact factor: 56.272

3.  Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study.

Authors:  B D Bilton; G B Zibari; R W McMillan; D F Aultman; G Dunn; J C McDonald
Journal:  Am Surg       Date:  1998-05       Impact factor: 0.688

4.  A comparison of the socioeconomic and health status characteristics of uninsured, state Children's health insurance program-eligible children in the united states with those of other groups of insured children: implications for policy.

Authors:  G R Byck
Journal:  Pediatrics       Date:  2000-07       Impact factor: 7.124

5.  Necrotizing soft tissue infections. Risk factors for mortality and strategies for management.

Authors:  D C Elliott; J A Kufera; R A Myers
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

6.  Burn center management of necrotizing soft-tissue surgical infections in unburned patients.

Authors:  L D Faucher; S E Morris; L S Edelman; J R Saffle
Journal:  Am J Surg       Date:  2001-12       Impact factor: 2.565

7.  Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults.

Authors:  P M Lantz; J S House; J M Lepkowski; D R Williams; R P Mero; J Chen
Journal:  JAMA       Date:  1998-06-03       Impact factor: 56.272

8.  Hospital volume and operative mortality in cancer surgery: a national study.

Authors:  Emily V A Finlayson; Philip P Goodney; John D Birkmeyer
Journal:  Arch Surg       Date:  2003-07

9.  Risk for severe group A streptococcal disease among patients' household contacts.

Authors:  Katherine A Robinson; Gretchen Rothrock; Quyen Phan; Brenda Sayler; Karen Stefonek; Chris Van Beneden; Orin S Levine
Journal:  Emerg Infect Dis       Date:  2003-04       Impact factor: 6.883

10.  Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention.

Authors: 
Journal:  Clin Infect Dis       Date:  2002-09-26       Impact factor: 9.079

View more
  12 in total

Review 1.  Management and Novel Adjuncts of Necrotizing Soft Tissue Infections.

Authors:  Christine S Cocanour; Phillip Chang; Jared M Huston; Charles A Adams; Jose J Diaz; Charles B Wessel; Bonnie A Falcione; Graciela M Bauza; Raquel A Forsythe; Matthew R Rosengart
Journal:  Surg Infect (Larchmt)       Date:  2017-04-04       Impact factor: 2.150

Review 2.  Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes.

Authors:  Timo W Hakkarainen; Nicole M Kopari; Tam N Pham; Heather L Evans
Journal:  Curr Probl Surg       Date:  2014-06-12       Impact factor: 1.909

3.  Not just full of hot air: hyperbaric oxygen therapy increases survival in cases of necrotizing soft tissue infections.

Authors:  Joshua J Shaw; Charles Psoinos; Timothy A Emhoff; Shimul A Shah; Heena P Santry
Journal:  Surg Infect (Larchmt)       Date:  2014-05-01       Impact factor: 2.150

4.  Transfer Is Associated with a Higher Mortality Rate in Necrotizing Soft Tissue Infections.

Authors:  Mitri K Khoury; Maryanne L Pickett; Michael W Cripps; So-Youn Park; Madjuri B Nagaraj; Tjasa Hranjec; Sara A Hennessy
Journal:  Surg Infect (Larchmt)       Date:  2019-08-26       Impact factor: 2.150

Review 5.  A Multi-Center Review of Care Patterns and Outcomes in Necrotizing Soft Tissue Infections.

Authors:  Iris Faraklas; Derek Yang; Michael Eggerstedt; Yan Zhai; Patrick Liebel; Gareth Graves; Sharmila Dissanaike; Michael Mosier; Amalia Cochran
Journal:  Surg Infect (Larchmt)       Date:  2016-11-11       Impact factor: 2.150

6.  Local variations in the epidemiology, microbiology, and outcome of necrotizing soft-tissue infections: a multicenter study.

Authors:  Lillian S Kao; Debbie F Lew; Samer N Arab; S Rob Todd; Samir S Awad; Matthew M Carrick; Michael G Corneille; Kevin P Lally
Journal:  Am J Surg       Date:  2011-05-04       Impact factor: 2.565

7.  Contemporary trends in necrotizing soft-tissue infections in the United States.

Authors:  Charles M Psoinos; Julie M Flahive; Joshua J Shaw; Youfu Li; Sing Chau Ng; Jennifer F Tseng; Heena P Santry
Journal:  Surgery       Date:  2013-02-27       Impact factor: 3.982

8.  Contemporary trends of the epidemiology, clinical characteristics, and resource utilization of necrotizing fasciitis in Texas: a population-based cohort study.

Authors:  Lavi Oud; Phillip Watkins
Journal:  Crit Care Res Pract       Date:  2015-03-29

9.  Necrotizing Fasciitis Associated with Pregnancy: a Population-Based Cohort Study.

Authors:  Lavi Oud; Phillip Watkins
Journal:  Infect Dis Ther       Date:  2014-07-29

10.  Determinants of Home Discharge Among Survivors of Necrotizing Fasciitis: A Population-Level Analysis.

Authors:  Lavi Oud
Journal:  J Clin Med Res       Date:  2016-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.